California Public Employees Retirement System Arvinas, Inc. Transaction History

California Public Employees Retirement System

$147 Billion
Q4 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$60.45 - $84.26 $3.37 Million - $4.7 Million	-55,738 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$58.19 - $91.37 $218,910 - $343,733	-3,762 Reduced 6.32%	55,738 $3.68 Million
Q4 2020 Feb 02, 2021	SELL	$20.19 - $84.93 $137,756 - $579,477	-6,823 Reduced 10.29%	59,500 $5.05 Million
Q3 2020 Nov 05, 2020	BUY	$22.99 - $36.34 $12,161 - $19,223	529 Added 0.8%	66,323 $1.57 Million
Q2 2020 Aug 12, 2020	BUY	$29.88 - $56.74 $554,094 - $1.05 Million	18,544 Added 39.25%	65,794 $2.21 Million
Q1 2020 May 12, 2020	BUY	$33.0 - $54.5 $432,300 - $713,950	13,100 Added 38.36%	47,250 $1.9 Million
Q4 2019 Jan 27, 2020	BUY	$15.39 - $44.38 $525,568 - $1.52 Million	34,150 New	34,150 $1.4 Million

Others Institutions Holding ARVN

# of Institutions

224

Shares Held

70.9M

Call Options Held

1.52M

Put Options Held

346K

Vanguard Group Inc Valley Forge, PA

7.06M
Shares

$131 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

6.73M
Shares

$125 Million
6.03% of portfolio
Black Rock Inc. New York, NY

6.26M
Shares

$116 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.1M
Shares

$76.1 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

3.33M
Shares

$61.8 Million
1.04% of portfolio

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $986M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account